Enews from the Alzheimer's Association

Having trouble viewing this message? You may view it as a web page. You may also view e-news archives.
To prevent mailbox filters from deleting your Alzheimer's Association email communications, please add alzheimers_enews@alz.org to your address book.
November 30, 2022
 
24/7 Helpline: 800.272.3900
Lecanemab shows potential as Alzheimer’s treatment
The drug lecanemab shows potential as an Alzheimer’s disease treatment, according to new Phase 3 trial results. Lecanemab is an experimental dementia drug that appears to slow the progression of cognitive decline. The Alzheimer’s Association is encouraged by these results and calls for the U.S. Food and Drug Administration’s accelerated approval of lecanemab.

Click here to read more
Respite care may help Alzheimer’s caregivers recharge
Respite care provides caregivers a temporary break while a person living with Alzheimer's continues to receive care in a safe environment. Using respite services can support and strengthen your ability to be a caregiver.
Click here to read more
Help fight Alzheimer's
Your Local Community
 
People living with Alzheimer's can take action to help others
People living with Alzheimer's have a unique opportunity to turn their experience into inspiration for others. Their voice and actions are powerful tools that can help to raise concern and awareness and empower others.
Click here to read more
Create a free, customized action plan with Alzheimer's Navigator.
 
More Resources: 
Stages of Alzheimer's  | 
Behaviors  | 
Coping Strategies  | 
Care Training
My Preferences:
Unsubscribe
To stop receiving our weekly e-newsletter, simply unsubscribe.
 
Subscribe
Was this e-newsletter forwarded to you? Subscribe to get it weekly.
The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.

 Alzheimer's Association Home Office 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
© 2022 Alzheimer's Association. All rights reserved. www.alz.org | 800.272.3900.